Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab

Keita Uchino, Hidekazu Sameshima, Toshihiro Miyamoto, Tadafumi Iino, Koji Kato, Hideho Henzan, Ken Ichi Aoki, Koji Nagafuji, Hisashi Gondo, Mine Harada

研究成果: ジャーナルへの寄稿学術誌査読

4 被引用数 (Scopus)

抄録

We report a 72-year-old man with Waldenström's macroglobulinemia (WM) in whom diffuse large B-cell lymphoma (DLCL) occurred 17 years after the diagnosis of WM. The malignant cells of both DLCL and WM expressed CD20 on their surface. CHOP plus anti-CD20 monoclonal antibody, rituximab, were effective for both diseases, and the patient remains disease-free 17 months later.

本文言語英語
ページ(範囲)131-134
ページ数4
ジャーナルInternal Medicine
43
2
DOI
出版ステータス出版済み - 2月 2004

!!!All Science Journal Classification (ASJC) codes

  • 内科学

フィンガープリント

「Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル